Table: Baseline Characteristics & Cox Proportional Hazards Model
Variable
Table 1: Baseline Characteristics
Table 2: Cox PH Results
N N = 2,3971 HR (95% CI) 95% CI p-value
Age (years) 2,397 42 (22)


Sex 2,397 1,011 (42%)


Tumor Topology 2,397



    AsanLezyon
472 (20%)


    BrainStem
154 (6.4%)


    Cerebellum
334 (14%)


    FrontalLobe
493 (21%)


    OccipitalLobe
82 (3.4%)


    ParietalLobe
309 (13%)


    TemporalLobe
462 (19%)


    Ventricle
91 (3.8%)


Histology Class 2,397



    Glioma
439 (18%)


    Astrocytic
523 (22%)


    Embryonal
89 (3.7%)


    Ependimoma
109 (4.5%)


    Glioblastoma
986 (41%)


    Lymphoma
49 (2.0%)


    Medulloblastoma
202 (8.4%)


Surgery Performed 2,397 2,135 (89%)


Radiotherapy 2,397 1,298 (54%)


Chemotherapy 2,397 591 (25%)


Age (per year)

1.02 1.01, 1.02 <0.001
Sex (Male vs Female)

0.96 0.86, 1.08 0.5
Topology (ref = AsanLezyon)




    AsanLezyon

— —
    BrainStem

0.92 0.68, 1.26 0.6
    Cerebellum

0.37 0.26, 0.54 <0.001
    FrontalLobe

0.80 0.67, 0.94 0.007
    OccipitalLobe

0.55 0.39, 0.77 <0.001
    ParietalLobe

0.62 0.51, 0.76 <0.001
    TemporalLobe

0.77 0.65, 0.92 0.003
    Ventricle

0.42 0.26, 0.67 <0.001
Histology (ref = Glioma)




    Glioma

— —
    Astrocytic

1.10 0.89, 1.37 0.4
    Embryonal

0.95 0.61, 1.49 0.8
    Ependimoma

1.45 0.95, 2.20 0.081
    Glioblastoma

4.31 3.56, 5.22 <0.001
    Lymphoma

3.18 2.15, 4.71 <0.001
    Medulloblastoma

2.38 1.53, 3.72 <0.001
Surgery (ref = no)

0.67 0.55, 0.81 <0.001
Radiotherapy (ref = no)

1.04 0.91, 1.18 0.6
Chemotherapy (ref = no)

0.88 0.76, 1.01 0.075
Abbreviations: CI = Confidence Interval, HR = Hazard Ratio
1 Mean (SD); n (%)